utrition the Unrecognized Determinant for Alzheimer's Disease (NUDAD-L) - NUDAD

Vrije Universiteit Medisch Centrum0 个研究点目标入组 90 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•Label of either subjective cognitive decline, Mild Cognitive Impairment or Alzheimer's Disease Signed informed consent projects P2005_160, P2000_211 (SCD: also SCIENCe P2014-019)
•Age * 50 years

•Individuals who are considered medically unstable (assessed by physician)
•Insufficient knowledge of Dutch language
•Major psychiatric disorder, such as psychosis, schizophrenia, severe personality disorder or depression with vital signs, abuse of alcohol or other substances
•Neurological disorder such as Parkinson*s disease, symptomatic stroke, mental retardation
•Having a history of other neurological disorders known to influence smell and/or taste
•Acquired Immune Deficiency Syndrome (AIDS) or Human Immunodeficiency Virus (HIV)
•Having a severe food allergy
•Having a severe disease of the digestive tract, such as celiac disease, Crohn*s disease, active ulcerative colitis, short bowel syndrome
•Having a severe metabolic disorder, such as phenyl ketonuria
•A recent diagnosis of cancer or being actively treated for cancer (excluding basal cell carcinoma of the skin)
•Having a current upper respiratory infection or severe COPD (known GOLD 3 or 4)
•Being a regular smoker
•In MCI and AD patients: unavailability of a study partner to assist with the participation of NUDAD-L in patients with dementia

发起方